Despite the significant contribution of the APOE genotype to AD risk, age of onset, and response to treatment, most research has concentrated on European or Asian populations, leaving a substantial knowledge gap regarding APOE’s influence of APOE on AD in genetically diverse African populations. The gene discussed is APOE; the disease is Alzheimer disease.